Atropine Sulfate · ATROPINE SULFATE 1 mg/mL · Solution · Intravenous · Somerset Therapeutics, LLC
NDC 70069-0641-25 · 25 VIAL in 1 CARTON / 1 mL in 1 VIAL · ANDA · View full market →
6 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now. One of its named manufacturing plants, Somerset Therapeutics Private Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Alcon Laboratories, Inc. | ATROPINE SULFATE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bausch & Lomb Americas Inc. | ATROPINE SULFATE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bausch & Lomb Incorporated | ATROPINE SULFATE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Medical Purchasing Solutions, LLC | ATROPINE SULFATE .4 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Medical Purchasing Solutions, LLC | ATROPINE SULFATE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| ProPharma Distribution | ATROPINE SULFATE .4 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Somerset Therapeutics, LLC | ATROPINE SULFATE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Somerset Therapeutics, LLC | ATROPINE SULFATE .4 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Atropine Sulfate — NDC 70069-0641-25," retrieved September 3, 2026, https://drugdashboards.com/drug/70069064125.
Free to cite with attribution — see how the data is put together.